Welcome and objectives

ESC Premium Access

Welcome and objectives

Session: Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation

Topic: Atrial Fibrillation, Other

Speaker: Professor G. Montalescot (Paris, FR)

Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Gilles Montalescot

Pitie Salpetriere APHP University Hospital, Paris (France)

35 presentations

1 follower

6 more presentations in this session

Anticoagulation in atrial fibrillation - Current landscape

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Access

Slides

Video

Establishing NOACs as standard of care in clinical practice

Speaker: Professor G. Lip (Liverpool, GB)

Access

Slides

Video

Exploring outstanding unmet needs in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention

Speaker: Professor R. Lopes (Durham, US)

Access

Slides

Video

Advancing patient care with NOACs in other cardiac interventions

Speaker: Professor G. Montalescot (Paris, FR)

Access

Slides

Video

Improving outcomes through atrial fibrillation screening - Future directions

Speaker: Professor R. Schnabel (Hamburg, DE)

Access

Slides

Video

Access the full session

Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation

Speakers: Professor G. Montalescot, Professor S. Hohnloser, Professor G. Lip, Professor R. Lopes, Professor G. Montalescot...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources